Vexev and U.S. Renal Care today announced successful results from the CANSCAN trial of the VxWave robotic ultrasound imaging system.
Vietnam Investment Review on MSN
Vexev's VxWave succeeds in dialysis vascular mapping trial
Vexev, announced the highly successful results of the CANSCAN Trial (NCT06691672), providing evidence that the VxWave ...
Vexev, an Australian-based medical device company advancing next-generation vascular imaging, and U.S. Renal Care, a leading ...
Capricor Therapeutics, Inc. ( CAPR) Q3 2025 Earnings Call November 10, 2025 4:30 PM EST Good afternoon, ladies and gentlemen, and welcome to the Capricor Therapeutics Third Quarter 2025 Conference ...
Q3 2025 Earnings Call Transcript November 10, 2025 Capricor Therapeutics, Inc. reports earnings inline with expectations.
Q3 2025 Earnings Call Transcript November 10, 2025 Myomo, Inc. beats earnings expectations. Reported EPS is $-0.09, ...
Of the more than one million high school football participants, only 3% make it to the Division I level — an extremely rare ...
After the event, CEO He emphasized that Xpeng’s ecosystem is more open than Tesla’s. The company will partner with Amap to ...
One of the most common genetic diseases, AATD, involves the retention of misfolded alpha 1 antitrypsin (AAT) in hepatocytes, ...
Background Pain and fatigue are among the most debilitating symptoms of systemic sclerosis (SSc), severely impairing quality ...
UBS Global Healthcare Conference 2025 November 10, 2025 2:00 PM ESTCompany ParticipantsAngela Wirick - Chief Financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback